"At Allergy Partners, we strive to be recognized as leaders in the development and delivery of high-quality health care for patients with asthma and allergic disease. Our vast care network of providers work together to promote education, research & innovation in the field of allergy & asthma care."

During the past decade, Allergy Partners of the Upstate conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Allergy Partners of the Upstate" are "Hereditary Angioedema" (2 trials). Many other conditions were trialed in "Allergy Partners of the Upstate" in a lesser frequency.

Most popular intervention types in "Allergy Partners of the Upstate" are "Biological" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "C1 esterase inhibitor [human] (C1INH-nf)" (2 trials) and "Placebo (saline)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Allergy Partners of the Upstate" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Allergy Partners of the Upstate". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Allergy Partners of the Upstate, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Allergy Partners of the Upstate, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".